---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-080304"
form_type: "8-K"
ticker: "FRMM"
cik: "0001690080"
company_name: "FORUM MARKETS Inc"
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:23:54.008080+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# 180 Life Sciences Corp. announces 1-for-20 reverse stock split to comply with Nasdaq minimum bid price

## Summary
- Reverse stock split at 1-for-20 approved by stockholders on Dec 15, effective Dec 19, 2022.
- Shares outstanding reduced from ~40.5M to ~2.0M; trading symbol ATNF unchanged.
- Split intended to regain compliance with Nasdaq $1.00 minimum bid price requirement.
- No fractional shares issued; rounded up to whole share; par value remains $0.0001.
- CUSIP number changes to 68236V203; board set ratio at 1-for-20.

## SEC filing metadata
- accession: 0001213900-22-080304
- form_type: 8-K
- ticker: FRMM
- cik: 0001690080
- company_name: FORUM MARKETS Inc
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690080/000121390022080304/0001213900-22-080304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690080/000121390022080304/ea170293-8k_180lifesci.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-080304
- JSON: https://secwatch.observer/filing/0001213900-22-080304.json
- Plain text: https://secwatch.observer/filing/0001213900-22-080304.txt

## Key facts
- Governance Changes
  FORUM MARKETS Inc: Approved an amendment to the Second Amended and Restated Certificate of Incorporation to effect a 1-for-20 reverse stock split, filed with the Delaware Secretary of State on December 15, 2022, effective December 19, 2022 (effective 2022-12-19).
  - Change: charter amendment
  - Effective: 2022-12-19
  source text: Immediately after the Special Meeting and the approval thereof by the Board, on December 15, 2022, we filed a Certificate of Amendment to our Second Amended and Restated Certificate of Incorporation (the “ Certificate of Amendment ”) with the Secretary of State of the State of Delaware to effect the Reverse Stock Split. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and is incorporated by reference herein. Pursuant to the Certificate of Amendment, the Reverse Stock Split will be effective on December 19, 2022 at 12:01 a.m. Eastern Time (the “ Effective Time ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390022080304/0001213900-22-080304-index.htm
- Shareholder Votes
  FORUM MARKETS Inc shareholders approved Reverse stock split of common stock at ratio between 1-for-4 and 1-for-20, inclusive, with exact ratio set by Board at the 2022-12-15 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2022-12-15
  source text: on December 15, 2022, at a Special Meeting of the Stockholders (the “ Special Meeting ”), of 180 Life Sciences Corp. (the “ Company, ” “ we, ” “ our, ” or “ us ”), the stockholders of the Company approved an amendment to the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of our common stock, par value $0.0001 per share, by a ratio of between one-for-four to one-for-twenty, inclusive, with the exact ratio to be set at a whole number to be determined by our Board of Directors or a duly authorized committee thereof in its discretion, at any time after approval of the amendment and prior to December 15, 2023 (the “ Stockholder Authority ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390022080304/0001213900-22-080304-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.